Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54(1):147–76.
Google Scholar
Viale L, Allotey J, Cheong-See F, Arroyo-Manzano D, McCorry D, Bagary M, Mignini L, Khan KS, Zamora J, Thangaratinam S, et al. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet. 2015;386(10006):1845–52.
Google Scholar
Wang ML, Tao YY, Sun XY, Guo Y, Wang ZY, Cao YF, Zhao L. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: recommendations for pregnant women with epilepsy. Pharmacol Res. 2021;169:105610.
Google Scholar
Nucera B, Brigo F, Trinka E, Kalss G. Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide. Ther Adv Neurol Disord. 2022;15:17562864221101687.
Google Scholar
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17(6):530–8.
Google Scholar
Diederich S, Hemmeter U, Paulmann M, Mockenhaupt M. Effects of dosage in new users of lamotrigine inducing epidermal necrolysis: results of the German registry of severe skin reactions. Epilepsia. 2023;64(5):1259–65.
Google Scholar
Martinez-Fierro ML, Garza-Veloz I, Zorrilla-Alfaro SM, Campuzano-Garcia AE, Rodriguez-Borroel M. Peripheral blood mononuclear cells cytokine profile in a patient with toxic epidermal necrolysis triggered by lamotrigine and COVID-19: a case study. Int J Mol Sci. 2025;26(3).
Deng E, Craig TJ, Nguyen DV, Al-Shaikhly T. COVID-19 and severe cutaneous allergic reactions to sulfonamides. Allergy Asthma Proc. 2024;45(6):e93–100.
Google Scholar
Bastuji-Garins. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.
Google Scholar
Marianne L, Carlo M, Benedetta TB-P, Thomas H. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2017;54(1).
Viale L, Allotey J, Cheong-See F, Arroyo-Manzano D, McCorry D, Bagary M, Mignini L, Khan KS, Zamora J, Thangaratinam S. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet. 2015;386(10006):1845–52.
Google Scholar
Liu H, Yang J, Liu R. A case of toxic epidermal necrolysis caused by lamotrigine combined with valproic acid and literature review. Cureus. 2023;15(9):e45334.
Google Scholar
Lofton AL, Klein-Schwartz W. Evaluation of lamotrigine toxicity reported to poison centers. Annals Pharmacotherapy. 2004;38(11):1811–5.
Ordonez L, Salgueiro E, Jimeno FJ, Manso G. Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs. Eur Rev Med Pharmacol Sci. 2015;19(14):2732–7.
Google Scholar
Glahn JZ, Almeida MN, Kochen A, Noel O, Stogner V, Hsia HC, Savetamal A. Lamotrigine emerging as a driver of Stevens-Johnson syndrome and toxic epidermal necrolysis: an 8-year retrospective study. Burns: J Int Soc Burn Injuries. 2024;50(8):2114–23.
Farooq O, Abbas A, Ahmad M, Manzoor AB. Lamotrigine-associated toxic epidermal necrolysis. Pakistan J Med Sci. 2023;39(6):1883–6.
Pa B, G SS, Thomas G, Kp A. Dosage optimization of lamotrigine in pregnancy: a pharmacometric approach using modeling and simulation. J Clin Pharmacol. 2022;62(12):1557–65.
Google Scholar
Roberti R, De Caro C, Iannone LF, Zaccara G, Lattanzi S, Russo E. Pharmacology of cenobamate: mechanism of action, pharmacokinetics, drug-drug interactions and tolerability. CNS Drugs. 2021;35(6):609–18.
Google Scholar
Hsu DY, Brieva J, Silverberg NB, Silverberg JI. Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults. J Invest Dermatol. 2016;136(7):1387–97.
Google Scholar
Wadelius M, Karlsson T, Wadelius C, Rane A. Lamotrigine and toxic epidermal necrolysis. Lancet. 1996;348(9033):1041.
Google Scholar
Perucca E, Brodie MJ, Kwan P, Tomson T. 30 years of second-generation antiseizure medications: impact and future perspectives. Lancet Neurol. 2020;19(6):544–56.
Google Scholar
Sabourirad S, Mortezaee R, Mojarad M, Eslahi A, Shahrokhi Y, Kiafar B, Jarahi L, Afkhami Ardakani S, Farrokhi S. Investigating the association of lamotrigine and phenytoin-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with HLA-B*1502 in Iranian population. Exp Dermatol. 2021;30(2):284–7.
Google Scholar
Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol. 2012;11(9):792–802.
Google Scholar
Kennedy GM, Lhatoo SD. CNS adverse events associated with antiepileptic drugs. CNS Drugs. 2008;22(9):739–60.
Google Scholar
Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, Nelson MR, Foot E. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19(9):661–5.
Google Scholar
Kc KK, Limbu T, Maskay SS, Bhasima A, Acharya SP. Lamotrigine induced toxic epidermal necrolysis: a case report. Annals Med Surg (2012). 2020;60:468–70.
Jenei Kluch L, Erdei I, Remenyik E, Suranyi E, Bodnar F, Emri G, Szegedi A. Does the dose of the culprit drug matter in hypersensitivity reactions? Orv Hetil. 2020;161(46):1959–65.
Google Scholar
Sukasem C, Sririttha S, Chaichan C, Nakkrut T, Satapornpong P, Jaruthamsophon K, Jantararoungtong T, Koomdee N, Medhasi S, Oo-Puthinan S, et al. Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis. Pharmacogenomics J. 2021;21(6):682–90.
Google Scholar
Deng Y, Li S, Zhang L, Jin H, Zou X. Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: a meta-analysis. Seizure. 2018;60:163–71.
Google Scholar
Rashid M, Rajan AK, Chhabra M, Kashyap A, Chandran VP, Venkataraman R, Nair S, Thunga G. Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a meta-analysis. Seizure. 2022;102:36–50.
Google Scholar
An DM, Wu XT, Hu FY, Yan B, Stefan H, Zhou D. Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population. Epilepsy Res. 2010;92(2–3):226–30.
Google Scholar
Diphoorn J, Cazzaniga S, Gamba C, Schroeder J, Citterio A, Rivolta AL, Vighi GD, Naldi L. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Northern Italy: data from the REACT registry. Pharmacoepidemiol Drug Saf. 2016;25(2):196–203.
Google Scholar
Bloom R, Amber KT. Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials. An Bras Dermatol. 2017;92(1):139–41.
Google Scholar
Fukasawa T, Takahashi H, Takahashi K, Tanemura N, Amagai M, Urushihara H. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: matched case-control and cohort studies. Allergology International: Official J Japanese Soc Allergology. 2021;70(3):335–42.
Park HJ, Kim SR, Leem DW, Moon IJ, Koh BS, Park KH, Park JW, Lee JH. Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine. Eur J Clin Pharmacol. 2015;71(1):35–41.
Google Scholar
Sullivan JR, Watson A. Lamotrigine-induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management. Australas J Dermatol. 1996;37(4):208–12.
Google Scholar
Fernández-Calvo C, Olascoaga J, Resano A, Urcola-Echevarria J, Turneu A, Zubizarreta J. Lyell’s syndrome associated with lamotrigine. RN. 2000;31(12):1162–4.
Google Scholar
Payam T-F, Marta JP, Jeffrey RS, Stephen EM, John JZ. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol. 2002;47(4).
Sladden M, Mortimer N, Chave T. Toxic epidermal caused by lamotrigine. Aus Fam Physician. 2004;33(10):829–30.
Chuan-Chia C, I-Shin S, Hsin-An C, San-Yuan H. Toxic epidermal necrolysis with combination lamotrigine and valproate in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2005;30(1).
Isabel R-B, Dolores S-A, Jaime T. Toxic epidermal necrolysis caused by lamotrigine. Actas Dermosifiliogr. 2006;96(2).
Susan PV, Linwood RH, Mary Lou P, Robert EG, Bruce HA. Lamotrigine-induced toxic epidermal necrolysis in three patients treated for bipolar disorder. Pharmacotherapy. 2006;26(5).
Duparc A, Lasek A, Gros C, Delaporte E, Van der Linden T, Modiano P. Nécrolyse épidermique toxique à La Lamotrigine par erreur de délivrance. Ann De Dermatologie Et De Vénéréologie. 2010;137(11):736–8.
Sofi FA, Koul PA, Mufti SA, Dhobi GN. Lamotrigine-induced toxic epidermal necrolysis in a young epileptic. BMJ case reports. 2011;2011.
Wang XQ, Lv B, Wang HF, Zhang X, Yu SY, Huang XS, Zhang JT, Tian CL, Lang SY. Lamotrigine-induced severe cutaneous adverse reaction: update data from 1999–2014. J Clin Neuroscience: Official J Neurosurgical Soc Australasia. 2015;22(6):1005–11.
Hsien-Te H, Chen-Lin C, Dong-Sheng T. Toxic epidermal necrolysis after sun-exposure probably due to lamotrigine and chlorpromazine. Asian J Psychiatr. 2010;3(4).
Manish JB, Mahendra KP, Tejas KP, CBT. Toxic epidermal necrolysis due to lamotrigine in a pediatric patient. J Pharmacol Pharmacother. 2013;3(4).
Kaur S, Dogra A. Toxic epidermal necrolysis due to concomitant use of lamotrigine and valproic acid. Indian J Dermatology. 2013;58(5):406.
Russomanno K, DiLorenzo A, Horeczko J, Deng M, Cardis M, Petronic-Rosic V, Johnson LS, Pasieka HB. Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure. JAAD Case Rep. 2021;14:68–71.
Google Scholar
Gaghan LJ, Coates MM, Crouse LN, Miedema J, Mervak JE, Ziemer CM. Photodistributed toxic epidermal necrolysis. JAMA Dermatology. 2022;158(7).
Koch S, Lösche G, Jager-Romän E, Jakob S, Rating D, Deichl A, Helge H. Major and minor birth malformations and antiepileptic drugs. Neurology. 1992;42(4 Suppl 5):83–8.
Google Scholar
Rosenow F, Winter Y, Leunikava I, Brunnert M, Joeres L, Sutphin J, Boeri M, Smith J, Villani F, Brandt C. Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: discrete choice experiment eliciting preferences in real-world study VOTE. Epilepsia. 2022;63(2):451–62.
Google Scholar
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, et al. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet. 2021;397(10282):1375–86.
Google Scholar
Bjørk MH, Zoega H, Leinonen MK, Cohen JM, Dreier JW, Furu K, Gilhus NE, Gissler M, Hálfdánarson Ó, Igland J, et al. Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability. JAMA Neurol. 2022;79(7):672–81.
Google Scholar
Cohen JM, Alvestad S, Cesta CE, Bjørk MH, Leinonen MK, Nørgaard M, Einarsdóttir K, Engeland A, Gissler M, Karlstad Ø, et al. Comparative safety of antiseizure medication monotherapy for major malformations. Ann Neurol. 2023;93(3):551–62.
Google Scholar
Chadwick D. The withdrawal of antiepileptic drugs. 1995.
Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology. 1992;42(4 Suppl 5):149–60.
Google Scholar
Clark CT. Psychotropic drug use in perinatal women with bipolar disorder. Semin Perinatol. 2020;44(3):151230.
Google Scholar
Kaplan YC, Demir O. Use of phenytoin, phenobarbital carbamazepine, levetiracetam lamotrigine and valproate in pregnancy and breastfeeding: risk of major malformations, dose-dependency, monotherapy vs polytherapy, pharmacokinetics and clinical implications. Curr Neuropharmacol. 2021;19(11):1805–24.
Google Scholar
Arfman IJ, Wammes-van der Heijden EA, Ter Horst PGJ, Lambrechts DA, Wegner I, Touw DJ. Therapeutic drug monitoring of antiepileptic drugs in women with epilepsy before, during, and after pregnancy. Clin Pharmacokinet. 2020;59(4):427–45.
Google Scholar
Fishel Bartal M, Sibai BM. Eclampsia in the 21st century. Am J Obstet Gynecol. 2022;226(2s):S1237–53.
Google Scholar
McAuley JW, Anderson GD. Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet. 2002;41(8):559–79.
Google Scholar
Davanzo R, Dal Bo S, Bua J, Copertino M, Zanelli E, Matarazzo L. Antiepileptic drugs and breastfeeding. Ital J Pediatr. 2013;39:50.
Google Scholar
Tomson T, Battino D, Bromley R, Kochen S, Meador KJ, Pennell PB, Thomas SV. Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE women task force. Epileptic Disorders: Int Epilepsy J Videotape. 2022;24(6):1020–32.
Cheung YK, Cheng SH, Chan EJ, Lo SV, Ng MH, Kwan P. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Epilepsia. 2013;54(7):1307–14.
Google Scholar
Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RC, Chu CY, Chen YT. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics. 2010;11(3):349–56.
Google Scholar
Dastgheib L, Rostami F, Gharesi-Fard B, Asadi-Pooya AA, Namjoo S, Tahmasebi F, Hadibarhaghtalab M. Association of human leukocyte antigen alleles with carbamazepine- or lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Iranian population: a case-control study. Iran J Med Sci. 2023;48(1):70–6.
Google Scholar
Ramírez E, Bellón T, Tong HY, Borobia AM, de Abajo FJ, Lerma V, Moreno Hidalgo MA, Castañer JL, Cabañas R, Fiandor A, et al. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population. Pharmacol Res. 2017;115:168–78.
Google Scholar